LAWRENCEVILLE, Ga. | The Rowen project is getting its first major tenant. UCB, a global biopharmaceutical company headquartered in Brussels, Belgium, will build its first U.S. pharmaceutical biologics manufacturing facility at Rowen, a 2,000-acre innovation and knowledge community in Gwinnett County. The $2 billion capital investment is the largest in Gwinnett County’s history and is projected to generate approximately $5 billion in total economic impact.
UCB focuses on developing medicines for people living with severe neurological and autoimmune conditions. The 460,000-square-foot facility, which will be located on approximately 79 acres within the Rowen community, brings advanced manufacturing onshore. It will feature a state-of-the-art, digital-first manufacturing approach leveraging artificial intelligence, robotics and advanced automation while prioritizing efficient use of natural resources.
Chairwoman Nicole Love Hendrickson, Gwinnett County Board of Commissioners, says: “We are thrilled that UCB has chosen Gwinnett County as its first-ever site in the U.S. to pioneer innovation and advance its global operations. This long-term investment reflects the collective vision we set in motion to establish Rowen, supported by the stability of our local government and our consistent approach to economic development. Gwinnett County offers a highly skilled workforce, world-class infrastructure and a quality of life that supports long-term success.”…